SchizophreniaDMTinSchizoNCT05500651
Dance and Movement Therapy in Patients With Schizophrenia
A study testing Dance and Movement Therapy (DMT) in people with Schizophrenia and Negative Symptoms in Schizophrenia, run by Amasya University at 1 site in Turkey (Türkiye).
Trial summary
Introduction: Schizophrenia is a mental disorder that starts at a young age and progresses with positive (hallucination, delusion) and negative (decreased emotional participation, reluctance) symptoms. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Schizophrenia, Negative Symptoms in Schizophrenia, Disabilities Mental
- What is being tested?
- Dance and Movement Therapy (DMT)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Sep 2022to 15 Feb 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- have been diagnosed with schizophrenia for at least two years
- not have been hospitalized in the past 3 months
Who cannot join
- have a therapy/psychoeducation program that they attend regularly
- have a known physical or neurological disease
- having just started the Community Mental Health Center
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Amasya Üniversitesi Sabuncuoğlu Şerefeddin Eğitim Ve Araştirma Hastanesi
Amasya
About this study
Official title: The Effect of Dance and Movement Therapy as a Group Work Technique on Negative Symptoms and Disability in Patients With Schizophrenia
Introduction: Schizophrenia is a mental disorder that starts at a young age and progresses with positive (hallucination, delusion) and negative (decreased emotional participation, reluctance) symptoms. While drug therapy in schizophrenia targets positive symptoms; psychotherapies are needed in the treatment of negative symptoms. It is seen that especially art therapies such as occupational and music support recovery and rehabilitation. In addition, it is stated that dance and movement therapy is effective in ensuring social participation of patients. There are a limited number of studies demonstrating the effect of dance and movement therapy on schizophrenia patients.
Aim: This project was planned to examine the effects of dance and movement therapy techniques to be applied to patients with schizophrenia on patients' negative symptoms and disability.
Read more
Method: In this project, which was planned in a repetitive measure design with a pretest-posttest control group, dance and movement therapy techniques, consisting of 12 sessions in total, will be applied to schizophrenic patients in a Community Mental Health Center once a week. Negative symptoms and disability levels will be determined before, after and a month after the application. The findings obtained as a result of these three follow-ups will be evaluated.
Project Outputs: Reduction of negative symptoms and disability will enable schizophrenic patients to become individuals who can express themselves better in their family and society and have an increased quality of life. It is thought that these gains will increase patients' compliance with treatment, prevent recurrent symptoms and reduce hospitalizations. The results will also constitute a scientific source for the studies to be carried out in the field.
- Being tested
- Dance and Movement Therapy (DMT)
- Keywords
- Dance and movement therapy
- Medical subject headings
- Schizophrenia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Dance and Movement Therapy (DMT)Other
Dance and movement therapy is planned to be applied once a week as a total of 12 sessions of 60 minutes. First session; meeting, warming up, determining the group rules, explaining the principles, determining the expectations activities. Subsequent sessions; The greeting is completed with warm-up, initiation, continuation and closing activities. During the warm-up phase, the whole group comes together to form a circle, generally standing, in order to ensure the group dynamic. It starts with simple warm-up exercises such as breathing and muscle relaxation and continues with body awareness exercises. In the continuation (development of themes) stage, practices are included according to the characteristics and needs of the group.
| Study group | Role | What they receive |
|---|---|---|
| Experimental group | Experimental | Dance and movement therapy is planned to be applied once a week as a total of 12 sessions of 60 minutes. First session; meeting, warming up, determining the group rules, explaining the principles, determining the expectations activities. Subsequent sessions; The greeting is completed with warm-up, initiation, continuation and closing activities. During the warm-up phase, the whole group comes together to form a circle, generally standing, in order to ensure the group dynamic. It starts with simple warm-up exercises such as breathing and muscle relaxation and continues with body awareness exercises. In the continuation (development of themes) stage, practices are included according to the characteristics and needs of the group. Receives: Other: Dance and Movement Therapy (DMT) |
| Control group | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
The Scale for the Assessment of Negative Symptoms (SANS)
Scale; It consists of five parts, including flattening or blunting in affect, alogy, decreased energy and desire, lack of pleasure and social withdrawal, attention, and a total of 24 items. Scale items 0=none; 1=doubtful; 2=light; 3=medium; 4=pronounced; It is scored as 5=severe. The negative symptoms rating scale is a type of scale that the interviewer evaluates. The filling of the scale is based on the interview with the patient, the observations during the interview and the information received from the people around the patient. Cronbach's alpha for the whole scale is 0.94.
Values that can be taken from the Scale for the Assessment of Negative Symptoms (SANS); minimum=0, maximum=120 points. It shows that as the score increases, the severity of negative symptoms increases.
Measured: 6 months
Disability Evaluation Schedule (WHO-DAS-II)
Disability Assessment Chart is a 36-item scale. This tool tries to determine how much difficulty an individual with schizophrenia has while performing certain activities and consists of 6 areas that include activities that are considered important in many cultures. These are grouped under the headings of understanding and communicating, moving and moving from place to place, self-care, human relations, life activities, participation in social life. In questions about all these areas, it is asked how much difficulty the person has had during that activity in the last month, and the answers received as not at all, mild, moderate, very much, excessively/not at all are scored between 1-5. It is applied by the interviewer in approximately 20 minutes. Cronbach's alpha for the whole scale is 0.92.
Values that can be taken from the Disability Evaluation Schedule (WHO-DAS-II); minimum=0, maximum=100 points. It shows that as the score increases, the severity of disability increases.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Aug 2022
- Study start1 Sep 2022
- Primary completion6 Dec 2022
- Study completion15 Feb 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SchizophreniaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- A repetitive measure design with a pretest-posttest control group
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Amasya University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gonca Ustun, Amasya University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05500651
- Sponsor's protocol ID
- AmasyaU8
- Acronym
- DMTinSchizo
- Status last verified
- May 2023
- First submitted
- 10 Aug 2022
- Last updated
- 23 May 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Dance and Movement Therapy as a Group Work Technique on Negative Symptoms and Disability in Patients With Schizophrenia
- ClinicalTrials.gov ID
- NCT05500651
- Acronym / sponsor ID
- DMTinSchizo / AmasyaU8
- Keywords
- Dance and movement therapy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Amasya UniversityUniversity, hospital or other
- Study start
- 1 Sep 2022 (actual)
- Primary completion
- 6 Dec 2022 (actual)
- Study completion
- 15 Feb 2023 (actual)
- First posted
- 15 Aug 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Introduction: Schizophrenia is a mental disorder that starts at a young age and progresses with positive (hallucination, delusion) and negative (decreased emotional participation, reluctance) symptoms. While drug therapy in schizophrenia targets positive symptoms; psychotherapies are needed in the treatment of negative symptoms. It is seen that especially art therapies such as occupational and music support recovery and rehabilitation. In addition, it is stated that dance and movement therapy is effective in ensuring social participation of patients. There are a limited number of studies demonstrating the effect of dance and movement therapy on schizophrenia patients.
Aim: This project was planned to examine the effects of dance and movement therapy techniques to be applied to patients with schizophrenia on patients' negative symptoms and disability.
Method: In this project, which was planned in a repetitive measure design with a pretest-posttest control group, dance and movement therapy techniques, consisting of 12 sessions in total, will be applied to schizophrenic patients in a Community Mental Health Center once a week. Negative symptoms and disability levels will be determined before, after and a month after the application. The findings obtained as a result of these three follow-ups will be evaluated.
Project Outputs: Reduction of negative symptoms and disability will enable schizophrenic patients to become individuals who can express themselves better in their family and society and have an increased quality of life. It is thought that these gains will increase patients' compliance with treatment, prevent recurrent symptoms and reduce hospitalizations. The results will also constitute a scientific source for the studies to be carried out in the field.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- A repetitive measure design with a pretest-posttest control group
| Arm | Type | Receives |
|---|---|---|
| Experimental group | Experimental | Other: Dance and Movement Therapy (DMT)Dance and movement therapy is planned to be applied once a week as a total of 12 sessions of 60 minutes. First session; meeting, warming up, determining the group rules, explaining the principles, determining the expectations activities. Subsequent sessions; The greeting is completed with warm-up, initiation, continuation and closing activities. During the warm-up phase, the whole group comes together to form a circle, generally standing, in order to ensure the group dynamic. It starts with simple warm-up exercises such as breathing and muscle relaxation and continues with body awareness exercises. In the continuation (development of themes) stage, practices are included according to the characteristics and needs of the group. |
| Control group | No intervention | – |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (2 listed)
- have been diagnosed with schizophrenia for at least two years
- not have been hospitalized in the past 3 months
Key exclusion criteria (3 listed)
- have a therapy/psychoeducation program that they attend regularly
- have a known physical or neurological disease
- having just started the Community Mental Health Center
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Dance and Movement Therapy (DMT)Dance and movement therapy is planned to be applied once a week as a total of 12 sessions of 60 minutes. First session; meeting, warming up, determining the group rules, explaining the principles, determining the expectations activities. Subsequent sessions; The greeting is completed with warm-up, initiation, continuation and closing activities. During the warm-up phase, the whole group comes together to form a circle, generally standing, in order to ensure the group dynamic. It starts with simple warm-up exercises such as breathing and muscle relaxation and continues with body awareness exercises. In the continuation (development of themes) stage, practices are included according to the characteristics and needs of the group. | Other | Experimental group |
Primary outcome
The Scale for the Assessment of Negative Symptoms (SANS)
Time frame: 6 months
Scale; It consists of five parts, including flattening or blunting in affect, alogy, decreased energy and desire, lack of pleasure and social withdrawal, attention, and a total of 24 items. Scale items 0=none; 1=doubtful; 2=light; 3=medium; 4=pronounced; It is scored as 5=severe. The negative symptoms rating scale is a type of scale that the interviewer evaluates. The filling of the scale is based on the interview with the patient, the observations during the interview and the information received from the people around the patient. Cronbach's alpha for the whole scale is 0.94. Values that can be taken from the Scale for the Assessment of Negative Symptoms (SANS); minimum=0, maximum=120 points. It shows that as the score increases, the severity of negative symptoms increases.
Disability Evaluation Schedule (WHO-DAS-II)
Time frame: 6 months
Disability Assessment Chart is a 36-item scale. This tool tries to determine how much difficulty an individual with schizophrenia has while performing certain activities and consists of 6 areas that include activities that are considered important in many cultures. These are grouped under the headings of understanding and communicating, moving and moving from place to place, self-care, human relations, life activities, participation in social life. In questions about all these areas, it is asked how much difficulty the person has had during that activity in the last month, and the answers received as not at all, mild, moderate, very much, excessively/not at all are scored between 1-5. It is applied by the interviewer in approximately 20 minutes. Cronbach's alpha for the whole scale is 0.92. Values that can be taken from the Disability Evaluation Schedule (WHO-DAS-II); minimum=0, maximum=100 points. It shows that as the score increases, the severity of disability increases.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 May 2023.
- Individual participant dataSharing planned: No
Related trials for Schizophrenia
RecruitingPhase 3
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Schizophrenia, Autism-Related Irritability
Not yet recruiting
Deep Brain Stimulation for Treatment-Resistant Schizophrenia
Treatment Resistant Disorders
Not yet recruitingObservational study
Sleep Monitoring for Early Detection of Relapse in People With Schizophrenia or Bipolar Disorder Receiving Usual Treatment
Bipolar Disorder (BD), SCHIZOPHRENIA 1 (Disorder)
Not yet recruitingPhase 1
Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult Participants
Healthy Adult Participants
Active, not recruiting
Designing and Evaluating a Classroom-Based Mental Health Programme for Adolescents.
Mental Health Promotion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Dance and Movement Therapy (DMT) in people with Schizophrenia and Negative Symptoms in Schizophrenia, run by Amasya University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 May 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The Scale for the Assessment of Negative Symptoms (SANS) (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2023.